Fund picks 2021: Tapping into a world with a Covid-19 vaccine
Will increasing immunisation levels continue to revive the fortunes of value investors?
Investment
-
-
Andrzej Pioch: How we played equities through the US elections and vaccine breakthrough
The LGIM multi-index team has been underweight US stocks during 2020 due to concerns about mega caps
-
I’ll be home for Christmas… with Brooks Macdonald’s Isobel Gingell
In a festive series investment experts reflect on an extraordinary year and their hopes for 2021
-
I’ll be home for Christmas… with Brewin Dolphin’s Janet Mui
In a festive series investment experts reflect on an extraordinary year and their hopes for 2021
-
Coronavirus weekly round-up: Boris refuses to ‘cancel Christmas’ as Covid cases surge in the South East
Four investors mull the events shaping portfolios over the past week
-
Covid pandemic let investment trusts shine in 2020 amid dividend destruction
Investment trusts can save up to 15% of dividends received in any given year for a rainy day
-
I’ll be home for Christmas… with EQ Investors’ Tertius Bonnin
In a festive series investment experts reflect on an extraordinary year and their hopes for 2021
-
Schroders raises another £75m from second trust IPO in a month
Schroder BSC Social Impact is the third investment trust from the funds giant tapping into UK private markets
-
Nick Train admits his 20th year running Finsbury Growth & Income was disappointing
Investment trust outperforms the FTSE All Share but still falls over 10% for the year
-
I’ll be home for Christmas… with Psigma Investment Management’s Rory McPherson
In a festive series investment experts reflect on an extraordinary year and their hopes for 2021
-
ASI could set an M&A trend in deal with investment trust specialist
‘An open-ended equivalent wouldn’t have been anywhere near as attractive’
-
Charles Plowden regrets Zoom miss as Baillie Gifford colleagues rake in millions
Zoom’s share price has increased over fivefold thanks to the Covid crisis
